Shattuck Labs, Inc. Revenue Breakdown
No Revenue Breakdown for STTK on this site yet.
- 2025-12-31: Others Not split by product in the filing$1.00M100.00%; Total revenue $1.00M.
- 2024-12-31: Others Not split by product in the filing$5.72M100.00%; Total revenue $5.72M.
- 2023-12-31: Others Not split by product in the filing$1.66M100.00%; Total revenue $1.66M.
- 2022-12-31: Others Not split by product in the filing$652.00K100.00%; Total revenue $652.00K.
Source checked: the stored Revenue Breakdown page for STTK.
Revenue by product
Each year (12 month)
| Fiscal year end | Others | Total revenue |
|---|---|---|
| 2025-12-31 | Not split by product in the filing $1.00M 100.00% | $1.00M |
| 2024-12-31 | Not split by product in the filing $5.72M 100.00% | $5.72M |
| 2023-12-31 | Not split by product in the filing $1.66M 100.00% | $1.66M |
| 2022-12-31 | Not split by product in the filing $652.00K 100.00% | $652.00K |
| 2021-12-31 | Not split by product in the filing $30.02M 100.00% | $30.02M |
| 2020-12-31 | Not split by product in the filing $9.93M 100.00% | $9.93M |
| 2019-12-31 | Not split by product in the filing $9.89M 100.00% | $9.89M |
Each quarter (3 month)
| Quarter end | Others | Total revenue |
|---|---|---|
| 2026-06-30 | Not split by product $0.00 | $0.00 |
| 2026-03-31 | Not split by product $0.00 | $0.00 |
| 2025-12-31 | Not split by product $0.00 | $0.00 |
| 2025-09-30 | Not split by product $1.00M 100.00% | $1.00M |
| 2025-06-30 | Not split by product $0.00 | $0.00 |
| 2025-03-31 | Not split by product $0.00 | $0.00 |
| 2024-12-31 | Not split by product $0.00 | $0.00 |
| 2024-09-30 | Not split by product $3.00M 100.00% | $3.00M |
| 2024-06-30 | Not split by product $1.61M 100.00% | $1.61M |
| 2024-03-31 | Not split by product $1.11M 100.00% | $1.11M |
| 2023-12-31 | Not split by product $714.00K 100.00% | $714.00K |
| 2023-09-30 | Not split by product $686.00K 100.00% | $686.00K |
| 2023-06-30 | Not split by product $200.00K 100.00% | $200.00K |
| 2023-03-31 | Not split by product $57.00K 100.00% | $57.00K |
| 2022-12-31 | Not split by product $390.00K 100.00% | $390.00K |
| 2022-09-30 | Not split by product $212.00K 100.00% | $212.00K |
| 2022-06-30 | Not split by product $50.00K 100.00% | $50.00K |
| 2022-03-31 | Not split by product $0.00 | $0.00 |
| 2021-12-31 | Not split by product $30.08M 100.00% | $30.08M |
| 2021-09-30 | Not split by product $1.90M 100.00% | $1.90M |
| 2021-06-30 | Not split by product -$4.23M 100.00% | -$4.23M |
| 2021-03-31 | Not split by product $2.27M 100.00% | $2.27M |
| 2020-12-31 | Not split by product $1.34M 100.00% | $1.34M |
| 2020-09-30 | Not split by product $2.44M 100.00% | $2.44M |
| 2020-06-30 | Not split by product $3.18M 100.00% | $3.18M |
| 2020-03-31 | Not split by product $2.98M 100.00% | $2.98M |
| 2019-12-31 | Not split by product $2.82M 100.00% | $2.82M |
| 2019-09-30 | Not split by product $1.78M 100.00% | $1.78M |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Neurogene Inc. (NGNE) | $0.625B | -4.46 | |
| BlossomHill Therapeutics, Inc. (BLSM) | United States | $0.647B | |
| IMPACT BIOMEDICAL INC. (IBO) | United States | $0.611B | 66.47 |
| Aquestive Therapeutics, Inc. (AQST) | United States | $0.606B | -6.67 |
| CorMedix Inc. (CRMD) | United States | $0.605B | 3.25 |
| ZEVRA THERAPEUTICS, INC. (ZVRA) | United States | $0.668B | 14.61 |
| CytomX Therapeutics, Inc. (CTMX) | United States | $0.598B | -10.25 |
| Monopar Therapeutics (MNPR) | United States | $0.598B | -34.82 |
| Altimmune, Inc. (ALT) | United States | $0.593B | -6.43 |
| Climb Bio, Inc. (CLYM) | United States | $0.683B | -13.03 |